Page last updated: 2024-08-24

triazoles and DIPG Brain Tumors

triazoles has been researched along with DIPG Brain Tumors in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Breur, M; Bugiani, M; Buil, LCM; de Gooijer, MC; Hashizume, R; Hulleman, E; Kaspers, GJL; Koster, J; Lagerweij, T; Meel, MH; Metselaar, DS; Montero Carcaboso, Á; Phoenix, TN; Raabe, EH; Sewing, ACP; Twisk, JWR; van Tellingen, O; van Vuurden, DG; Waranecki, P; Wedekind, LE; Zwaan, K	1
Carcaboso, AM; Diederichs, C; Gielen, GH; Hamdan, FH; Hulleman, E; Johnsen, SA; Kramm, CM; Kubiak, K; Nussbaumer, G; Wiese, M	1

Other Studies

2 other study(ies) available for triazoles and DIPG Brain Tumors

Article	Year
Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 07-01, Volume: 26, Issue:13 Topics: Animals; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Biomarkers, Tumor; Blood-Brain Barrier; Cell Line, Tumor; Combined Modality Therapy; Diffuse Intrinsic Pontine Glioma; Disease Models, Animal; Drug Synergism; Epithelial-Mesenchymal Transition; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Immunohistochemistry; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Triazoles; Xenograft Model Antitumor Assays	2020
Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells. Cell death & disease, 2020, 08-21, Volume: 11, Issue:8 Topics: Acetylation; Astrocytoma; Azepines; Brain Stem Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; CREB-Binding Protein; Diffuse Intrinsic Pontine Glioma; Gene Expression Regulation, Neoplastic; Glioma; Histones; Humans; Mutation; Nuclear Proteins; Nucleosomes; Proteins; Pyrimidinones; Transcription Factors; Transcriptional Activation; Triazoles	2020

Article

Year

Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 07-01, Volume: 26, Issue:13

Topics: Animals; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Biomarkers, Tumor; Blood-Brain Barrier; Cell Line, Tumor; Combined Modality Therapy; Diffuse Intrinsic Pontine Glioma; Disease Models, Animal; Drug Synergism; Epithelial-Mesenchymal Transition; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Immunohistochemistry; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Triazoles; Xenograft Model Antitumor Assays

2020

Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells.

Cell death & disease, 2020, 08-21, Volume: 11, Issue:8

Topics: Acetylation; Astrocytoma; Azepines; Brain Stem Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; CREB-Binding Protein; Diffuse Intrinsic Pontine Glioma; Gene Expression Regulation, Neoplastic; Glioma; Histones; Humans; Mutation; Nuclear Proteins; Nucleosomes; Proteins; Pyrimidinones; Transcription Factors; Transcriptional Activation; Triazoles

2020